🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Flumatinib is an orally available TKI with high selectivity and potency aga...
Status
Not Yet Recruiting
Location
Institute of Hematology and Oncology, Harbin The First Hospital
Start Date
2022-04-30
Trial ID
NCT05367765
Treatments Being Tested
A study to observe the efficacy and the safety of Flumatinib vs Imatinib as...
Status
Completed
Location
Hospital of Blood Diseases, Chinese Academy of Medical Sciences
Start Date
2014-06
Trial ID
NCT02204644
Treatments Being Tested
It's a double-blind , randomized ,multi-center study. The purpose of this s...
Status
Unknown
Location
Institute of Hematology and Oncology, Harbin The First Hospital
Start Date
2021-11-23
Trial ID
NCT05353205
Treatments Being Tested
Imatinib has revolutionized the treatment of chronic myeloid leukemia (CML)...
Status
Unknown
Location
Weiming Li
Start Date
2020-11-01
Trial ID
NCT04681820
Treatments Being Tested
It is an open-label, randomized, multi-center study. The efficacy and safet...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2011-08
Trial ID
NCT01503502
Treatments Being Tested